These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31840871)

  • 21. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for the management of vasa previa.
    Gagnon R; ;
    J Obstet Gynaecol Can; 2009 Aug; 31(8):748-753. PubMed ID: 19772710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasa Previa: Prenatal Diagnosis and Outcomes: Thirty-five Cases From a Single Maternal-Fetal Medicine Practice.
    Kulkarni A; Powel J; Aziz M; Shah L; Lashley S; Benito C; Oyelese Y
    J Ultrasound Med; 2018 Apr; 37(4):1017-1024. PubMed ID: 29048133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center.
    Smorgick N; Tovbin Y; Ushakov F; Vaknin Z; Barzilay B; Herman A; Maymon R
    J Clin Ultrasound; 2010; 38(3):118-22. PubMed ID: 20091699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third-trimester fetoscopic ablation therapy for types II and III vasa previa.
    Chmait RH; Monson MA; Chon AH; Masri J; Korst LM; Incerpi MH
    Am J Obstet Gynecol; 2024 Jan; 230(1):87.e1-87.e9. PubMed ID: 37741533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal diagnosis and management of vasa previa: a 6-year review.
    Kanda E; Matsuda Y; Kamitomo M; Maeda T; Mihara K; Hatae M
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1391-6. PubMed ID: 21599804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome.
    Lee W; Lee VL; Kirk JS; Sloan CT; Smith RS; Comstock CH
    Obstet Gynecol; 2000 Apr; 95(4):572-6. PubMed ID: 10725492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.
    Syngelaki A; Hammami A; Bower S; Zidere V; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):468-476. PubMed ID: 31408229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal diagnosis of velamentous umbilical cord insertion and vasa previa with color Doppler imaging.
    Nomiyama M; Toyota Y; Kawano H
    Ultrasound Obstet Gynecol; 1998 Dec; 12(6):426-9. PubMed ID: 9918092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we perform a prenatal diagnosis of vasa previa to improve its obstetrical and neonatal outcomes?
    Nohuz E; Boulay E; Gallot D; Lemery D; Vendittelli F
    J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):373-377. PubMed ID: 28643667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of risk for vasa previa at 9-13 weeks' gestation.
    Hasegawa J; Nakamura M; Sekizawa A; Matsuoka R; Ichizuka K; Okai T
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1346-51. PubMed ID: 21564407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal heart rate patterns of pregnancies with vasa previa and velamentous cord insertion.
    Baumfeld Y; Gutvirtz G; Shoham I; Sheiner E
    Arch Gynecol Obstet; 2016 Feb; 293(2):361-7. PubMed ID: 26193955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in reported outcomes in studies on vasa previa: a systematic review.
    Villani LA; Pavalagantharajah S; D'Souza R
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100116. PubMed ID: 33345867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasa previa and associated risk factors: a systematic review and meta-analysis.
    Pavalagantharajah S; Villani LA; D'Souza R
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100117. PubMed ID: 33345868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of vasa previa.
    Bręborowicz GH; Markwitz W; Szpera-Goździewicz A; Dera-Szymanowska A; Ropacka-Lesiak M; Szymański P; Kubiaczyk-Paluch B
    J Matern Fetal Neonatal Med; 2015; 28(15):1806-8. PubMed ID: 25338011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of vasa previa screening into a routine anomaly scan: A single center cohort study.
    Nwandison M; Daly-Jones E; Drought A; Story L; De-Rosnay P; Sebire N; Nyberg D; Oyelese Y
    Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1466-1473. PubMed ID: 38594913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasa previa: prenatal diagnosis and management.
    Melcer Y; Maymon R; Jauniaux E
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):385-391. PubMed ID: 30102606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa.
    Melcer Y; Jauniaux E; Maymon S; Tsviban A; Pekar-Zlotin M; Betser M; Maymon R
    Am J Obstet Gynecol; 2018 Apr; 218(4):443.e1-443.e8. PubMed ID: 29353034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinatal Outcomes Associated With Isolated Velamentous Cord Insertion in Singleton and Twin Pregnancies.
    Sinkin JA; Craig WY; Jones M; Pinette MG; Wax JR
    J Ultrasound Med; 2018 Feb; 37(2):471-478. PubMed ID: 28850682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of routine ultrasound examination at 35-37 weeks' gestation in diagnosis of non-cephalic presentation.
    De Castro H; Ciobanu A; Formuso C; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):248-256. PubMed ID: 31671470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.